| BE0009-1MG
| InVivoMab anti-mouse CD18
| 1 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0002-25MG
| InVivoMab anti-mouse CD3
| 25 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0050-5MG
| InVivoMab anti-mouse IL-10R (CD210)
| 5 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0007-25MG
| InVivoMab anti-mouse/human CD11b
| 25 mg
| BioXCell
| in vivo CD11b neutralization, ILC2 cell purificati
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0052-25MG
| InVivoMab anti-mouse IL-12
| 25 mg
| BioXCell
| in vivo IL-12 neutralization, in vitro IL-12 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0042-50MG
| InVivoMab anti-mouse IL-2
| 50 mg
| BioXCell
| in vivo IL-2 neutralization, in vitro IL-2 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0001-1FAB 10MG
| InVivoMab anti-mouse CD3? F(ab')2 fragment
| 10 mg
| BioXCell
| in vivo T cell depletion
|
| Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0076-5MG
| InVivoMab anti-mouse Thy1 (CD90)
| 5 mg
| BioXCell
| in vitro T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0024-100MG
| InVivoMab anti-mouse CD80 (B7-1)
| 100 mg
| BioXCell
| In vivo CD80 blockade, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0063-50MG
| InVivoMab anti-mouse GITR
| 50 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0033-1-100MG
| InVivoMab anti-mouse OX40L (CD134L)
| 100 mg
| BioXCell
| in vivo blocking of OX40/OX40L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0003-2-50MG
| InVivoMab anti-human CD4
| 50 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0077-1MG
| InVivoMab anti-mouse MHC Class I (H-2)
| 1 mg
| BioXCell
| ex vivo blocking of MHC I–dependent interactions,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0028-25MG
| InVivoMab anti-mouse ICOSL (CD275)
| 25 mg
| BioXCell
| in vivo ICOSL neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0068-50MG
| InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7)
| 50 mg
| BioXCell
| in vitro MHC class II I-A blocking, in vitro MHC c
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0025-100MG
| InVivoMab anti-mouse CD86 (B7-2)
| 100 mg
| BioXCell
| In vivo CD86 blockade, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0086-25MG
| InVivoMab mouse IgG2b isotype control
| 25 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BE0025-50MG
| InVivoMab anti-mouse CD86 (B7-2)
| 50 mg
| BioXCell
| In vivo CD86 blockade, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0015-1-5MG
| InVivoMab anti-mouse CD28
| 5 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0003-3-1MG
| InVivoMab anti-mouse CD4
| 1 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0021-5MG
| InVivoMab anti-mouse L-Selectin (CD62L)
| 5 mg
| BioXCell
| In vivo CD62L neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0022-1MG
| InVivoMab anti-mouse CD70
| 1 mg
| BioXCell
| In vivo CD70 blockade, In vitro CD70 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0071-25MG
| InVivoMab anti-mouse/human VLA-4 (CD49d)
| 25 mg
| BioXCell
| in vivo VLA-4 neutralization, in vitro VLA-4 neutr
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0022-100MG
| InVivoMab anti-mouse CD70
| 100 mg
| BioXCell
| In vivo CD70 blockade, In vitro CD70 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0040-25MG
| InVivoMab anti-rat CD28
| 25 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, Flow cytom
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0058-100MG
| InVivoMab anti-mouse TNF?
| 100 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0085-1MG
| InVivoMab mouse IgG2a isotype control
| 1 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BE0057-5MG
| InVivoMab anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 5 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| mouse/human/rat/monkey/hamster/canine/bovin
| Solicitar Precio
| Solicitar
|
| BE0065-25MG
| InVivoMab anti-mouse IL-7R? (CD127)
| 25 mg
| BioXCell
| in vivo blocking of IL-7R? signaling, Flow cytomet
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0012-1MG
| InVivoMab anti-mouse CD25 (IL-2R?)
| 1 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0024-25MG
| InVivoMab anti-mouse CD80 (B7-1)
| 25 mg
| BioXCell
| In vivo CD80 blockade, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0072-25MG
| InVivoMab anti-mouse T15 VH and T15 VL regions of IgM
| 25 mg
| BioXCell
| ELISA
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0001-1-1MG
| InVivoMab anti-mouse CD3?
| 1 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0055-1MG
| InVivoMab anti-mouse IFN?
| 1 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0043-1-25MG
| InVivoMab anti-mouse IL-2
| 25 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0055-100MG
| InVivoMab anti-mouse IFN?
| 100 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0063-5MG
| InVivoMab anti-mouse GITR
| 5 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0054-50MG
| InVivoMab anti-mouse IFN?
| 50 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0020-1-1MG
| InVivoMab anti-mouse CD54 (ICAM-1)
| 1 mg
| BioXCell
| In vivo ICAM-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0075-1-5MG
| InVivoMab anti-mouse Ly6G
| 5 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0017-1-50MG
| InVivoMab anti-mouse CD154 (CD40L)
| 50 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0040-1MG
| InVivoMab anti-rat CD28
| 1 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, Flow cytom
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0111-50MG
| InVivoMab anti-mouse NKG2D
| 50 mg
| BioXCell
| in vivo NKG2D blockade
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0139-25MG
| InVivoMab anti-mouse/human/rat v-H-Ras
| 25 mg
| BioXCell
| Immunoprecipitation
|
| Rat
| mouse/human/ra
| Solicitar Precio
| Solicitar
|
| BE0095-50MG
| InVivoMab polyclonal rabbit IgG
| 50 mg
| BioXCell
|
|
| Rabbit
| N/
| Solicitar Precio
| Solicitar
|
| BE0096-50MG
| InVivoMab recombinant human IgG1 Fc
| 50 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BE0155-100MG
| InVivoMab anti-mouse Delta-like protein 1 (DLL1)
| 100 mg
| BioXCell
| in vivo DLL1 neutralization, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0187-1MG
| InVivoMab anti-rat CD80
| 1 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0115-50MG
| InVivoMab anti-mouse TIM-3 (CD366)
| 50 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0179-25MG
| InVivoMab anti-mouse CD1d (CD1.1)
| 25 mg
| BioXCell
| iNKT cell neutralization, in vivo CD1d blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|